期刊文献+

端粒延长替代机制与DNA修复途径 被引量:3

Alternative Lengthening of Telomere and DNA Repair
原文传递
导出
摘要 端粒长度和结构的稳定与肿瘤及衰老的发生密切相关,端粒维持机制(telomere maintenance mechanism,TMM)的激活对稳定基因组和建立细胞永生化至关重要。85%~90%的肿瘤细胞是通过激活端粒酶来维持端粒长度的,10%~15%的肿瘤细胞在端粒酶失活或不足的情况下,利用同源重组或其他多种机制维持端粒长度,这些端粒维持机制统称为端粒延长替代机制(alterative lengthening of telomere,ALT)。ALT端粒DNA通过染色体外游离的端粒重复DNA来合成。这提示,在ALT端粒维持时进行的DNA修复机制可能有利于阐明衰老与肿瘤之间的辩证关系。该文从ALT端粒DNA维持的角度,阐述和总结了ALT肿瘤中几种DNA修复途径及ALT活性相关蛋白如何维持端粒长度和功能的完整性。 The maintenance of telomere length and structure is highly related to the progress of senescence and tumorigenesis. Activation of a telomere maintenance mechanism(TMM) is of crucial importance for genome stability and the establishment of cellular immortality. 85%-90% of the tumor cells reactivate telomerase to maintain telomere length, while 10%-15% of the tumor cells utilize homologous recombination or other mechanisms to main telomere length in the case of telomerase deficiency. These mechanisms are referred to as alternative lengthening of telomere(ALT). ALT telomere DNA is synthesized by extrachromosomal free telomeric repeat DNA. Which implicated that DNA repair pathways engaged in ALT telomere maintenance might facilitate the understanding of the crosstalk between senescence and tumorigenesis. From the perspective of ALT telomere DNA, we discuss how DNA repair pathways converage in ALT mechanism and the proteins involved in maintaining the length and functional integrity of telomere in ALT cancers.
作者 张永进 李海丽 李翠 邵驰浩 罗瑛 Zhang Yongjin;Li Haili;Li Cui;Shao Chihao;Luo Ying(Lab of Molecular Genetics of Aging and Tumor,Faculty of Medicine,Kunming University of Science and Technology,Kunming 650224,China)
出处 《中国细胞生物学学报》 CAS CSCD 2018年第8期1430-1437,共8页 Chinese Journal of Cell Biology
基金 昆明理工大学分析测试基金(批准号:2017M20162136009)资助的课题~~
关键词 端粒延长替代机制 端粒 DNA修复 同源重组 alterative lengthening of telomere telomere DNA repair homologous recombination
  • 相关文献

参考文献1

二级参考文献34

  • 1Laud PR, Multani AS, Bailey SM, Wu L, Ma J, Kingsley C, Lebel M, Pathak S, DePinho RA, Chang S. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev, 2005, 19(21): 2560-2570.
  • 2Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev, 2003, 17(1): 88-100.
  • 3Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J, 1995, 14(17): 4240-4248.
  • 4Henderson S, Allsopp R, Spector D, Wang SS, Harley C. In situ analysis of changes in telomere size during replicative aging and cell transformation. J Cell Biol, 1996, 134(1): 1-12.
  • 5Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oneogene, 2002, 21(4): 598-610.
  • 6Jegou T, Chung I, Heuvelman G, Wachsmuth M, Gorisch SM, Greulich-Bode KM, Boukamp P, Lichter P, Rippe K. Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell line. Mol Biol Cell, 2009, 20(7): 2070-2082.
  • 7Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res, 1999, 59(17): 4175-4179.
  • 8Potts PR, Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol, 2007, 14(7): 581-590.
  • 9Grobelny JV, Godwin AK, Broccoli D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J Cell Sci, 2000, 113(Pt 24): 4577-4585.
  • 10Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC, Reddel RR. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MREll/RAD50/NBS1 complex. Mol Cell Biol, 2005, 25(7): 2708-2721.

共引文献8

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部